tradingkey.logo
tradingkey.logo
Search

Immuneonco Biopharmaceuticals Shanghai Says Clearance Of Ind Application For Imm2510/Axn-2510 By FDA

ReutersJul 2, 2025 10:24 AM
facebooktwitterlinkedin

- ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:

  • CLEARANCE OF IND APPLICATION FOR IMM2510/AXN-2510 BY U.S. FDA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI